For Lamekia Davis, assuming the role of executive director of the Meredith A. Cowden Foundation is a natural evolution of her life-long passion to help others that took hold when she was just a child. “When I was 11 years old, my mom was diagnosed with stage IV breast...
Since the Foundation’s inception in 2007, the Cowden family’s multi-faceted understanding and lived experience with GVHD—both from the patient and caregiver standpoint—has informed the direction of the Foundation both through our founders, Gerry & Marti Cowden,...
Gerald W. Cowden Founder and Chair Emeritus, Meredith A. Cowden Foundation Gerald "Gerry" W. Cowden is a retired Cleveland-based attorney whose four-decade legal career focused on entrepreneurs, growing businesses, and the investors who support them. He received his...
If you were alive in the 1980’s, you may have heard G.I. Joe impart this important piece of wisdom at the end of an episode: “Now you know…and knowing is half the battle.” The other half of the battle—as anyone living with a chronic disease like graft vs. host disease...
On December 18, 2024, the Food and Drug Administration approved remestemcel-L-rknd (Ryoncil, Mesoblast, Inc.), an allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy, for steroid-refractory acute graft versus host disease (SR-aGVHD) in pediatric...
WILMINGTON, Del.--(BUSINESS WIRE)--Feb. 27, 2024-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for axatilimab, an anti-CSF-1R antibody, for the treatment...
Check out the latest season of the Marrow Masters podcast. This season, titled "I'm Home, Now What?" dives into a crucial phase of the journey – the period after returning home. It offers invaluable insights, guidance, and support for individuals who have completed...
Serving up Nutritional Know How and Resources as We Gear Up for the Holidays When: Wednesday, December 13, 2023 at Noon EST Note: start time will vary by time zone The nbmtLINK invites you to participate in this FREE session. Register Here Today! A Telephone Support...
Improving Life for Patients with cGVHD with a Focus on Lung Issues, Psychosocial Support, a Personal Perspective, and More When: Wednesday, December 6, 2023 at Noon EST to 1:30 pm EST (1.5 hours) Note: start time will vary by time zone • Closed Captioning Available...
Let’s spread some love this National Family Caregivers Month! As a caregiver, you know caregiving is one of the hardest and most loving things a family member, a friend, or a professional can do for someone with blood cancer. Every act matters—whether it’s taking care...
Let's Tackle It All: Guidance for the Long Haul Post Transplant Read more about this important, free event below. The date is Nov. 8, 2023, from Noon to 1:30 pm EST. This program will offer Closed Captioning. [button...
A FREE Call In Telephone Support Program for Patients and Their Families/ Caregivers/ Loved Ones Presented by the National Bone Marrow Transplant Link, www.nbmtlink.org Lunch & Learn with the LINK: Navigating the Emotional Rollercoaster of Cancer Special thanks to...
This month’s call-in program will focus on BMT care partners. Michelle M. Bishop, PhD, a licensed psychologist specialized in coping with cancer and caregiving, will talk about what the BMT survivorship road is like for many family caregivers, noting that it can be...
A Telephone Support Program for Patients,Families/Caregivers/Loved Ones Wednesday, July 19 NOON EST (one hour) This month’s call-in program will focus on finding your new normal post-transplant. Rita Abdallah, LISW-S, ACSW, Speaker & Wellness Coach, willbreak it...
Special thanks to our generous sponsors: The Leukemia & Lymphoma Society, Incyte, Omeros Corporation and Pharmacyclics & Janssen. We also thank our Esteemed Link Partners. This month’s call-in program will focus on Myelodysplastic syndromes (MDS). Dr. Arpita...
On February 17th, for the first time in history, world-renowned health and cancer organizations joined forces to raise awareness for GVHD during the now-annual “GVHD Day.” It was hugely impactful, and we’re incredibly proud of the work that both our team and our...
Leading Transplant Organizations Unite as GVHD Alliance,Announce Inaugural GVHD Day on February 17, 2023 Graft-Versus-Host Disease (GVHD) is a rare disease that commonly impacts allogeneic blood and marrow transplant recipients1 New GVHD Alliance aims to bridge...
We have some exciting news to share! We’re thrilled to announce that we are a founding member of the newly formed GVHD Alliance
The National Bone Marrow Transplant Link, www.nbmtlink.org invites you to participate in a FREE webinar that will help you and your loved ones better understand Graft Versus Host Disease Thursday, Jan. 27, 20221:30 PM EST - Start time may vary by time zone To Register...
GVHD EVENT DATE AND TIME: Friday, November 20th, 2020 1 pm to 3 pm EST Chronic GvHD Consensus Conference Patient Advocacy Summit Event Website and Registration: https://ncifrederick.cancer.gov/events/conferences/2020ChronicGVHDConsensus/advocacysummit Registration is...